Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
REATA PHARMACEUTICALS INC | VP, Chief Accounting Officer | Class A common stock | 14.5K | $2.5M | $172.03 | Jun 9, 2021 | Direct |
REATA PHARMACEUTICALS INC | VP, Chief Accounting Officer | Employee Stock Option (right to buy) | 9.93K | Jun 9, 2021 | Direct | ||
REATA PHARMACEUTICALS INC | VP, Chief Accounting Officer | Class B common stock | 0 | $172.03 | Jun 9, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RETA | REATA PHARMACEUTICALS INC | Jun 7, 2021 | 12 | -$1.2M | 4 | Jun 9, 2021 | VP, Chief Accounting Officer |
RETA | REATA PHARMACEUTICALS INC | May 26, 2021 | 7 | -$1.05M | 4 | May 27, 2021 | VP, Chief Accounting Officer |